Kurt Zatloukal describes the progress made in the Instand-NGS4P project towards developing integrated and standardized NGS workflows for common and rare cancers in adults and children, followed by keynote lectures from Matthias Schwab on the importance of pharmacogenomics and Jean-Yves Blay on the current challenges for precision medicine in cancer. The innovative developments will be presented by some of the companies participating in the project.
DFP points: 2
Registration by Thursday 4th April: formular.medunigraz.at/form/provide/4207
